Scientists test pill to block dengue virus in human challenge trial
NCT ID NCT06528457
Summary
This study tested whether an oral medication called fenretinide (ISLA101) could control dengue virus infection. Fifteen healthy volunteers were given either the drug or a placebo, then deliberately exposed to a weakened form of the dengue virus. Researchers measured if the drug, taken either before or after exposure, could reduce the amount of virus in the blood and lessen symptoms over 29 days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DENGUE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
SUNY Upstate Medical University
East Syracuse, New York, 13057, United States
Conditions
Explore the condition pages connected to this study.